Developing vaccines to protect against infectious diseases and bioterrorism
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
This study is working on developing new vaccines to help protect us from infectious diseases, whether they come from nature or are released on purpose, and it's all about making sure these vaccines are safe and effective before they are used.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Immunartes LLC NIH-funded |
| Lab location | 1 site (Willowbrook, UNITED STATES) |
| Project ID | NIH-11250891 on NIH RePORTER |
What this research studies
This research focuses on creating and testing vaccine candidates that can be used in response to outbreaks of infectious diseases, whether they occur naturally or are intentionally released. The approach includes formulating and manufacturing vaccine components, conducting stability tests, and evaluating their effectiveness and safety through studies in animal models. By advancing these vaccine candidates, the research aims to ensure preparedness against potential health threats.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk of exposure to infectious diseases or those living in areas prone to outbreaks.
Not a fit: Patients who are not at risk of infectious diseases or those who have existing immunity to the targeted pathogens may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect against serious infectious diseases and enhance public health safety.
How similar studies have performed: Previous research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising potential for this approach.
Where this research is happening
Willowbrook, UNITED STATES
- Immunartes LLC — Willowbrook, United States (Active)
Researchers
- Principal investigator: Thammavongsa, Vilasack — Immunartes LLC
- Study coordinator: Thammavongsa, Vilasack
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.